A carregar...
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
The use of activated factor VII (FVIIa) for the treatment of bleeding events in haemophilia patients with inhibitors was first reported over 30 years ago. Since then clinical trials, registries, case series, real‐world experience and an understanding of its mechanism of action have transformed what...
Na minha lista:
| Publicado no: | Haemophilia |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899648/ https://ncbi.nlm.nih.gov/pubmed/31489759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13845 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|